106 related articles for article (PubMed ID: 23353551)
1. Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq™ 2.0 genotyping system as a gold standard.
Chaturbhuj DN; Deshmukh PS; Hingankar NK; Siddhaarth K; Deshpande SN; Sen S; Kabra S; Paranjape RS; Tripathy SP
J Virol Methods; 2013 Apr; 189(1):87-92. PubMed ID: 23353551
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.
Xu S; Zhong P; Li J; Song A; Li H; Nie J; Li X; Wang Y
Mol Diagn Ther; 2011 Feb; 15(1):41-52. PubMed ID: 21469769
[TBL] [Abstract][Full Text] [Related]
3. Comparison between an in-house method and the ViroSeq™ method for determining mutations for drug resistance in the HIV-1 CRF01_AE subtype circulating in China.
Li H; Liang S; Guo W; Zhuang D; Li L; Liu Y; Bao Z; Liu S; Wang X; Li T; Liu W; Li J
J Virol Methods; 2014 Sep; 205():17-23. PubMed ID: 24814966
[TBL] [Abstract][Full Text] [Related]
4. Performance comparison of an in-house integrase genotyping assay versus the ViroSeq™ Integra48, and study of HIV-1 integrase polymorphisms in Hong Kong.
To SW; Chen JH; Wong KH; Chan KC; Ng HM; Wu H; Lam JT; Yam WC
J Clin Virol; 2013 Sep; 58(1):299-302. PubMed ID: 23886504
[TBL] [Abstract][Full Text] [Related]
5. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.
Chen JH; Wong KH; Chan K; Lam HY; Lee SS; Li P; Lee MP; Tsang DN; Zheng BJ; Yuen KY; Yam WC
J Clin Virol; 2007 Jun; 39(2):125-31. PubMed ID: 17449318
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a cost effective in-house method for HIV-1 drug resistance genotyping using plasma samples.
Chaturbhuj DN; Nirmalkar AP; Paranjape RS; Tripathy SP
PLoS One; 2014; 9(2):e87441. PubMed ID: 24533056
[TBL] [Abstract][Full Text] [Related]
8. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of an in-house human immunodeficiency virus (HIV) genotyping assay for the detection of drug resistance mutations in HIV-1 infected patients in Singapore.
Chew KK; Ng KY; Khong WX; Kaur P; Yap JK; Chua A; Tan MT; Koh YL; Thoon KC; Leo YS; Ng OT
Ann Acad Med Singap; 2012 Dec; 41(12):553-8. PubMed ID: 23303111
[TBL] [Abstract][Full Text] [Related]
10. Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon.
Fokam J; Salpini R; Santoro MM; Cento V; D'Arrigo R; Gori C; Perno CF; Colizzi V; Nanfack A; Gwom LC; Cappelli G; Takou D
Arch Virol; 2011 Jul; 156(7):1235-43. PubMed ID: 21465085
[TBL] [Abstract][Full Text] [Related]
11. Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.
Wallis CL; Viana RV; Saravanan S; Silva de Jesus C; Zeh C; Halvas EK; Mellors JW
J Virol Methods; 2017 Mar; 241():41-45. PubMed ID: 27993614
[TBL] [Abstract][Full Text] [Related]
12. Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.
Muñoz M; Carmona R; Pérez-Alvarez L; Cilla G; Suarez MD; Delgado E; Contreras G; Corral J; de Goicoetxea MJ; Medrano L; Lezaún MJ; Nájera R;
J Clin Virol; 2005 Jul; 33(3):224-9. PubMed ID: 15911444
[TBL] [Abstract][Full Text] [Related]
13. Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: analysis of primary resistance mutations.
de Medeiros RM; Junqueira DM; Matte MC; Barcellos NT; Chies JA; Matos Almeida SE
J Med Virol; 2011 Oct; 83(10):1682-8. PubMed ID: 21837783
[TBL] [Abstract][Full Text] [Related]
14. A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts.
Ziemniak C; George-Agwu A; Moss WJ; Ray SC; Persaud D
J Virol Methods; 2006 Sep; 136(1-2):238-47. PubMed ID: 16828172
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus type 1 drug resistance testing: Evaluation of a new ultra-deep sequencing-based protocol and comparison with the TRUGENE HIV-1 Genotyping Kit.
Stelzl E; Pröll J; Bizon B; Niklas N; Danzer M; Hackl C; Stabentheiner S; Gabriel C; Kessler HH
J Virol Methods; 2011 Dec; 178(1-2):94-7. PubMed ID: 21907239
[TBL] [Abstract][Full Text] [Related]
16. [Feasibility of using dried blood spots to detect HIV drug resistance genotyping].
Ma PF; Xing H; Liao LJ; Chen B; Zhao QB; Quan Y; Sun F; Yang SM; Su B; Chen X; Shao YM
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Nov; 44(11):993-8. PubMed ID: 21215126
[TBL] [Abstract][Full Text] [Related]
17. In-house human immunodeficiency virus-1 genotype resistance testing to determine highly active antiretroviral therapy resistance mutations in Hong Kong.
Chen JH; Wong KH; Li PC; Chan KK; Lee MP; To SW; Yam WC
Hong Kong Med J; 2012 Feb; 18(1):20-4. PubMed ID: 22302906
[TBL] [Abstract][Full Text] [Related]
18. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes.
Aitken SC; Kliphuis A; Wallis CL; Chu ML; Fillekes Q; Barth R; Stevens W; Rinke de Wit TF; Schuurman R
J Clin Virol; 2012 May; 54(1):21-5. PubMed ID: 22306272
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1 drug resistance testing: a comparison of three sequence-based methods.
Erali M; Page S; Reimer LG; Hillyard DR
J Clin Microbiol; 2001 Jun; 39(6):2157-65. PubMed ID: 11376051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
